China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China
· Delayed Price · Currency is CNY 20.92
+0.03 (0.14%)
Mar 10, 2026, 12:34 PM CST
SHE:300294 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 761.75 | 1,300 | 1,961 | 1,532 | 1,584 | 753.89 | Upgrade
|
| Trading Asset Securities | 2,355 | 2,199 | 3,362 | 3,194 | 2,700 | - | Upgrade
|
| Cash & Short-Term Investments | 3,116 | 3,499 | 5,324 | 4,726 | 4,284 | 753.89 | Upgrade
|
| Cash Growth | -40.52% | -34.28% | 12.66% | 10.31% | 468.21% | 32.55% | Upgrade
|
| Accounts Receivable | 732.8 | 509.38 | 275.92 | 567.02 | 588.08 | 681.01 | Upgrade
|
| Other Receivables | 88.7 | 39.81 | 264.4 | 100.62 | 67.9 | 53.21 | Upgrade
|
| Receivables | 821.5 | 549.19 | 540.32 | 667.64 | 655.98 | 734.22 | Upgrade
|
| Inventory | 1,119 | 995.43 | 556.94 | 666.96 | 676.84 | 689.46 | Upgrade
|
| Other Current Assets | 57.43 | 14.75 | 6.43 | 13.25 | 29.4 | 750.08 | Upgrade
|
| Total Current Assets | 5,115 | 5,058 | 6,428 | 6,073 | 5,646 | 2,928 | Upgrade
|
| Property, Plant & Equipment | 1,502 | 1,170 | 676.62 | 722.81 | 771.33 | 809.52 | Upgrade
|
| Long-Term Investments | 131.26 | 81.09 | 100.39 | 117.09 | 144.96 | 311.66 | Upgrade
|
| Goodwill | 728 | 728 | 72.61 | 663.84 | 663.84 | 663.84 | Upgrade
|
| Other Intangible Assets | 663.59 | 773.28 | 269.31 | 312.17 | 169.47 | 198.6 | Upgrade
|
| Long-Term Deferred Tax Assets | 76.25 | 73.54 | 47.34 | 44.99 | 27.44 | 20.57 | Upgrade
|
| Long-Term Deferred Charges | 139.41 | 145.9 | 88.15 | 82.64 | 161.62 | 166.41 | Upgrade
|
| Other Long-Term Assets | 372.51 | 370.79 | 146.83 | 16.24 | 37.2 | 60.27 | Upgrade
|
| Total Assets | 8,727 | 8,401 | 7,829 | 8,033 | 7,622 | 5,159 | Upgrade
|
| Accounts Payable | 521.65 | 357.62 | 126.35 | 303.46 | 277.53 | 285.88 | Upgrade
|
| Accrued Expenses | 91.14 | 318.03 | 274.14 | 290.9 | 261.19 | 83.94 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 220.2 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.03 | 22.18 | 0.08 | 55.2 | Upgrade
|
| Current Portion of Leases | 2.55 | 5.33 | 0.87 | 2.81 | 2.06 | - | Upgrade
|
| Current Income Taxes Payable | 13.73 | 12.44 | 8.58 | 27.09 | 41.45 | 20.54 | Upgrade
|
| Current Unearned Revenue | 5.73 | 4.08 | 12.21 | 20.58 | 12.97 | 14.51 | Upgrade
|
| Other Current Liabilities | 283.69 | 52.88 | 34.26 | 38.33 | 35.66 | 191.66 | Upgrade
|
| Total Current Liabilities | 918.5 | 750.38 | 456.45 | 705.34 | 630.94 | 871.93 | Upgrade
|
| Long-Term Debt | 1.16 | - | 22.15 | - | 22.15 | 55 | Upgrade
|
| Long-Term Leases | 4.36 | 7.17 | 1.4 | 10.37 | 11.3 | - | Upgrade
|
| Long-Term Unearned Revenue | 17.86 | 19.51 | 23.52 | 27.09 | 30.98 | 32.44 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 112.78 | 136.32 | 4.56 | 5.56 | 5.94 | 6.71 | Upgrade
|
| Total Liabilities | 1,055 | 913.38 | 508.07 | 748.35 | 701.3 | 966.08 | Upgrade
|
| Common Stock | 504.25 | 504.25 | 504.25 | 504.25 | 511.63 | 433.32 | Upgrade
|
| Additional Paid-In Capital | 4,063 | 4,063 | 4,063 | 4,065 | 4,258 | 1,947 | Upgrade
|
| Retained Earnings | 3,104 | 2,918 | 2,753 | 2,616 | 2,259 | 1,928 | Upgrade
|
| Treasury Stock | - | - | - | - | -199.96 | -199.96 | Upgrade
|
| Comprehensive Income & Other | -0.68 | 2.36 | - | - | - | - | Upgrade
|
| Total Common Equity | 7,671 | 7,487 | 7,320 | 7,186 | 6,829 | 4,108 | Upgrade
|
| Minority Interest | 1.69 | 0.61 | 1.07 | 99.19 | 91.4 | 84.55 | Upgrade
|
| Shareholders' Equity | 7,672 | 7,488 | 7,321 | 7,285 | 6,920 | 4,192 | Upgrade
|
| Total Liabilities & Equity | 8,727 | 8,401 | 7,829 | 8,033 | 7,622 | 5,159 | Upgrade
|
| Total Debt | 8.08 | 12.51 | 24.45 | 35.36 | 35.58 | 330.39 | Upgrade
|
| Net Cash (Debt) | 3,108 | 3,486 | 5,299 | 4,690 | 4,248 | 423.5 | Upgrade
|
| Net Cash Growth | -40.62% | -34.21% | 12.99% | 10.41% | 903.09% | - | Upgrade
|
| Net Cash Per Share | 6.18 | 6.94 | 10.49 | 9.33 | 9.74 | 0.99 | Upgrade
|
| Filing Date Shares Outstanding | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | 425.94 | Upgrade
|
| Total Common Shares Outstanding | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | 425.94 | Upgrade
|
| Working Capital | 4,196 | 4,308 | 5,971 | 5,368 | 5,015 | 2,056 | Upgrade
|
| Book Value Per Share | 15.21 | 14.85 | 14.52 | 14.25 | 13.54 | 9.64 | Upgrade
|
| Tangible Book Value | 6,279 | 5,986 | 6,978 | 6,210 | 5,996 | 3,245 | Upgrade
|
| Tangible Book Value Per Share | 12.45 | 11.87 | 13.84 | 12.31 | 11.89 | 7.62 | Upgrade
|
| Buildings | - | 741.4 | 527.95 | 518.01 | 536.62 | 506.23 | Upgrade
|
| Machinery | - | 839.25 | 625.83 | 671.97 | 665.73 | 632.37 | Upgrade
|
| Construction In Progress | - | 321 | 39.94 | 69.34 | 40.86 | 80.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.